Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics

References

• Adcock, S. A., & McCammon, J. A. (2006). Molecular dynamics: Survey of methods for simulating the activity of proteins. Chemical Reviews, 106(5), 1589–1615. https://doi.org/https://doi.org/10.1021/cr040426m
   PubMed Web of Science ®Google Scholar
• Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012). Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood, 119(3), 651–665. https://doi.org/https://doi.org/10.1182/blood-2011-04-325225
   PubMed Web of Science ®Google Scholar
• Amin, M. L. (2013). P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights, 7, 27–34. https://doi.org/https://doi.org/10.4137/DTI.S12519
   PubMedGoogle Scholar
• Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. https://doi.org/https://doi.org/10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Beutler, B., & Cerami, A. (1986). Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature, 320(6063), 584–588. https://doi.org/https://doi.org/10.1038/320584a0
   PubMed Web of Science ®Google Scholar
• Bodmer, J. L., Schneider, P., & Tschopp, J. (2002). The molecular architecture of the TNF superfamily. Trends in Biochemical Sciences, 27(1), 19–26. https://doi.org/https://doi.org/10.1016/S0968-0004(01)01995-8
   PubMed Web of Science ®Google Scholar
• Bumbacea, D., Campbell, D., Nguyen, L., Carr, D., Barnes, P. J., Robinson, D., & Chung, K. F. (2004). Parameters associated with persistent airflow obstruction in chronic severe asthma. European Respiratory Journal, 24(1), 122–128. https://doi.org/https://doi.org/10.1183/09031936.04.00077803
   PubMed Web of Science ®Google Scholar
• Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences of the United States of America, 72(9), 3666–3670. https://doi.org/https://doi.org/10.1073/pnas.72.9.3666
   PubMed Web of Science ®Google Scholar
• Chan, D. S., Lee, H. M., Yang, F., Che, C. M., Wong, C. C., Abagyan, R., Leung, C. H., & Ma, D. L. (2010). Structure-based discovery of natural-product-like TNF-α inhibitors. Angewandte Chemie (International ed. in English)), 49(16), 2860–2864. https://doi.org/https://doi.org/10.1002/anie.200907360
   PubMed Web of Science ®Google Scholar
• Chen, Z., Li, H. L., Zhang, Q. J., Bao, X. G., Yu, K. Q., Luo, X. M., Zhu, W. L., & Jiang, H. L. (2009). Pharmacophore-based virtual screening versus docking-based virtual screening: A benchmark comparison against eight targets. Acta Pharmacologica Sinica, 30(12), 1694–1708. https://doi.org/https://doi.org/10.1038/aps.2009.159
   PubMed Web of Science ®Google Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/https://doi.org/10.1021/ci300367a
   PubMed Web of Science ®Google Scholar
• Choi, H., Lee, Y., Park, H., & Oh, D. S. (2010). Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters, 20(21), 6195–6198. https://doi.org/https://doi.org/10.1016/j.bmcl.2010.08.116
   PubMed Web of Science ®Google Scholar
• Clackson, T. (2006). Breaking and entering. Nature Chemical Biology, 2(1), 14–15. https://doi.org/https://doi.org/10.1038/nchembio0106-14
   PubMed Web of Science ®Google Scholar
• Coppack, S. W. (2001). Pro-inflammatory cytokines and adipose tissue. The Proceedings of the Nutrition Society, 60(3), 349–356. https://doi.org/https://doi.org/10.1079/pns2001110
   PubMed Web of Science ®Google Scholar
• Drews, J. (2000). Drug discovery: A historical perspective. Science (New York, N.Y.).), 287(5460), 1960–1964. https://doi.org/https://doi.org/10.1126/science.287.5460.1960
   PubMed Web of Science ®Google Scholar
• Fink, K., Martin, L., Mukawera, E., Chartier, S., De Deken, X., Brochiero, E., Miot, F., & Grandvaux, N. (2013). IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response. Cell Research, 23(5), 673–690. https://doi.org/https://doi.org/10.1038/cr.2013.47
   PubMed Web of Science ®Google Scholar
• Gravestein, L. A., & Borst, J. (1998). Tumor necrosis factor receptor family members in the immune system. Seminars in Immunology, 10(6), 423–434. https://doi.org/https://doi.org/10.1006/smim.1998.0144
   PubMed Web of Science ®Google Scholar
• Grazioli, L., Alzani, R., Ciomei, M., Mariani, M., Restivo, A., Cozzi, E., & Marcucci, F. (1992). Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha. International Journal of Immunopharmacology, 14(4), 637–642. https://doi.org/https://doi.org/10.1016/0192-0561(92)90125-5
   PubMed Web of Science ®Google Scholar
• Hamilton, L. M., Torres-Lozano, C., Puddicombe, S. M., Richter, A., Kimber, I., Dearman, R. J., Vrugt, B., Aalbers, R., Holgate, S. T., Djukanovic, R., Wilson, S. J., & Davies, D. E. (2003). The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clinical & Experimental Allergy, 33(2), 233–240. https://doi.org/https://doi.org/10.1046/j.1365-2222.2003.01593.x
   PubMed Web of Science ®Google Scholar
• He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., Fung, A. D., Farrington, G., Eldredge, J. K., Day, E. S., Cruz, L. A., Cachero, T. G., Miller, S. K., Friedman, J. E., Choong, I. C., & Cunningham, B. C. (2005). Small-molecule inhibition of TNF-alpha. Science (New York, N.Y.).), 310(5750), 1022–1025. https://doi.org/https://doi.org/10.1126/science.1116304
   PubMed Web of Science ®Google Scholar
• Jacobi, A., Mahler, V., Schuler, G., & Hertl, M. (2006). Treatment of inflammatory dermatoses by tumour necrosis factor antagonists. Journal of the European Academy of Dermatology and Venereology : Jeadv, 20(10), 1171–1187. https://doi.org/https://doi.org/10.1111/j.1468-3083.2006.01733.x
   PubMed Web of Science ®Google Scholar
• Kelker, H. C., Oppenheim, J. D., Stone-Wolff, D., Henriksen-DeStefano, D., Aggarwal, B. B., Stevenson, H. C., & Vilcek, J. (1985). Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. International Journal of Cancer, 36(1), 69–73. https://doi.org/https://doi.org/10.1002/ijc.2910360112
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Open Source Drug Discovery, C., & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lagorce, D., Sperandio, O., Baell, J. B., Miteva, M. A., & Villoutreix, B. O. (2015). FAF-Drugs3: A web server for compound property calculation and chemical library design. Nucleic Acids Research, 43(W1), W200–207. https://doi.org/https://doi.org/10.1093/nar/gkv353
   PubMed Web of Science ®Google Scholar
• Leach, A. R., Gillet, V. J., Lewis, R. A., & Taylor, R. (2010). Three-dimensional pharmacophore methods in drug discovery. Journal of Medicinal Chemistry, 53(2), 539–558. https://doi.org/https://doi.org/10.1021/jm900817u
   PubMed Web of Science ®Google Scholar
• Leung, C. H., Chan, D. S., Kwan, M. H., Cheng, Z., Wong, C. Y., Zhu, G. Y., Fong, W. F., & Ma, D. L. (2011). Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors. ChemMedChem, 6(5), 765–768. https://doi.org/https://doi.org/10.1002/cmdc.201100016
   PubMed Web of Science ®Google Scholar
• Leung, C. H., Zhong, H. J., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R., Wong, C. Y., & Ma, D. L. (2012). A metal-based inhibitor of tumor necrosis factor-α. Angewandte Chemie (International ed. in English)), 51(36), 9010–9014. https://doi.org/https://doi.org/10.1002/anie.201202937
   PubMed Web of Science ®Google Scholar
• Melagraki, G., Ntougkos, E., Rinotas, V., Papaneophytou, C., Leonis, G., Mavromoustakos, T., Kontopidis, G., Douni, E., Afantitis, A., & Kollias, G. (2017). Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL). PLoS Computational Biology, 13(4), e1005372. https://doi.org/https://doi.org/10.1371/journal.pcbi.1005372
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Pirhadi, S., Shiri, F., & Ghasemi, J. B. (2013). Methods and applications of structure based pharmacophores in drug discovery. Current Topics in Medicinal Chemistry, 13(9), 1036–1047. https://doi.org/https://doi.org/10.2174/1568026611313090006
   PubMed Web of Science ®Google Scholar
• Pronk, S., Pall, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (Oxford, England)), 29(7), 845–854. https://doi.org/https://doi.org/10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Saddala, M. S., & Huang, H. (2019). Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches . Journal of Translational Medicine, 17(1), 215. https://doi.org/https://doi.org/10.1186/s12967-019-1965-5
   PubMedGoogle Scholar
• Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443–447. https://doi.org/https://doi.org/10.1093/nar/gkv315
   PubMed Web of Science ®Google Scholar
• Sanguinetti, M. C., & Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia. Nature, 440(7083), 463–469. https://doi.org/https://doi.org/10.1038/nature04710
   PubMed Web of Science ®Google Scholar
• Schuttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Seidel, T., Ibis, G., Bendix, F., & Wolber, G. (2010). Strategies for 3D pharmacophore-based virtual screening. Drug Discovery Today: Technologies, 7(4), e221–e228. https://doi.org/https://doi.org/10.1016/j.ddtec.2010.12.004
   Google Scholar
• Shen, Q., Zhang, C., Liu, H., Liu, Y., Cao, J., Zhang, X., Liang, Y., Zhao, M., & Lai, L. (2016). De novo design of helical peptides to inhibit tumor necrosis factor-[small alpha] by disrupting its trimer formation. MedChemComm, 7(4), 725–729. https://doi.org/https://doi.org/10.1039/C5MD00549C
   Web of Science ®Google Scholar
• Shubayev, V. I., & Myers, R. R. (2000). Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Research, 855(1), 83–89. https://doi.org/https://doi.org/10.1016/S0006-8993(99)02321-5
   PubMed Web of Science ®Google Scholar
• Sinko, W., Miao, Y., de Oliveira, C. A., & McCammon, J. A. (2013). Population based reweighting of scaled molecular dynamics. The Journal of Physical Chemistry B, 117(42), 12759–12768. https://doi.org/https://doi.org/10.1021/jp401587e
   PubMed Web of Science ®Google Scholar
• Sun, H., & Yost, G. S. (2008). Metabolic Activation of a Novel 3-Substituted Indole-Containing TNF-alpha inhibitor: Dehydrogenation and inactivation of CYP3A4. Chemical Research in Toxicology, 21(2), 374–385. https://doi.org/https://doi.org/10.1021/tx700294g
   PubMed Web of Science ®Google Scholar
• Vassalli, P. (1992). The pathophysiology of tumor necrosis factors. Annual Review of Immunology, 10, 411–452. https://doi.org/https://doi.org/10.1146/annurev.iy.10.040192.002211
   PubMed Web of Science ®Google Scholar
• Vuorinen, A., & Schuster, D. (2015). Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. Methods (San Diego, Calif.).), 71, 113–134. https://doi.org/https://doi.org/10.1016/j.ymeth.2014.10.013
   PubMed Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260. https://doi.org/https://doi.org/10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998. Pure and Applied Chemistry, 70(5), 1129–1143. ). https://doi.org/https://doi.org/10.1351/pac199870051129
   Web of Science ®Google Scholar
• Wolber, G., & Langer, T. (2005). LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45(1), 160–169. https://doi.org/https://doi.org/10.1021/ci049885e
   PubMed Web of Science ®Google Scholar
• Wolber, G., Dornhofer, A. A., & Langer, T. (2006). Efficient overlay of small organic molecules using 3D pharmacophores. Journal of Computer-Aided Molecular Design, 20(12), 773–788. https://doi.org/https://doi.org/10.1007/s10822-006-9078-7
   PubMed Web of Science ®Google Scholar